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Microperfusion Studies on the Permeability
of Retinal Vessels
A New Model Demonstrating Organic Anion
Transport and a Reabsorptive Fluid Flux
J. N. Murra,* J. G. Cunha-Vaz,* C. A. Sobo,f C. W. Jones,t and M. E. Laskit
We developed an experimental model to study the permeability of individual retinal vessels in vitro
using microperfusion techniques adapted from kidney tubule studies. The retinal vessels were isolated
by freehand dissection and mounted on a microperfusion apparatus. When inulin was perfused lumin-
ally, it was diluted to 80.2 ± 2.3% of its initial concentration. However, no radioactive leak into the
bath side was observed, suggesting that the dilution was due to fluid flux from bath to lumen. The
dilution of fluorescein (81.9 ± 3.8%) was in the same range as that of inulin, the reference marker. The
extremely low lumen-to-bath fluorescein flux, 0.5 ± 0.9 X 10~12 mol/min/mm, increased by 68% when
probenecid was added to the perfusate and by 210% when probenecid was placed in the bath. The
effect was concentration-dependent. When placed in the bath, fluorescein moved rapidly across the
retinal vessel walls, accumulating in the lumen to concentrations 40 times higher than in the bath. This
movement from bath to lumen, which was much higher (13.6 ± 0.3 X 10~12 mol/min/mm) than the
lumen-to-bath fluorescein flux for the same fluorescein concentration, decreased by adding probenecid
to the bath. The kinetics of this unidirectional movement of fluorescein were consistent with a satura-
ble active transport process. The fluid flux from bath to lumen across the retinal vessels, which was 6.3
±1.0 nl/min/mm for perfusion rates of 6.6 ± 0.2 nl/min, was temperature-dependent and was coupled
to the fluorescein transport. Fluorescein stimulated the fluid flux by 17% when added to the perfusate
and by 60% when added to the bath, and this effect could be reversed by probenecid. Our results
showed an active transport of fluorescein in the rabbit retinal vessels coupled with net fluid flux from
outside the vessels into the lumen. Invest Ophthalmol Vis Sci 31:471-480,1990
The alteration of the functional characteristics of
the blood-retinal barriers appears to play a major role
in the pathophysiology of retinal disease. The wide-
spread use of fluorescein angiography and, more re-
cently, the development of vitreous fluorophotom-
etry have shown that a disturbance of these barriers
may precede the retinal changes in diabetes and other
retinal diseases.1"3
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The active transport of fluorescein, an organic
anion, across the retina was described initially by
Cunha-Vaz and Maurice,4 but its site (presumably
retinal vessels and retinal pigment epithelium) and
mode of action remained uncertain. Recently, this
transport mechanism has been confirmed,5 and di-
rect evidence of its location in the retinal pigment
epithelium has been presented.6 Studies on the retinal
vessels, however, still are lacking.
We developed a new experimental model to inves-
tigate the permeability of the retinal vessels using mi-
croperfusion techniques adapted from kidney tubule
studies.7"9 Application of this technology to vascular
physiology has been limited because of anatomic
problems involved in isolating individual small ves-
sels for microperfusion. Retinal vessels of rabbits are
appropriate for these studies, because the rabbit vas-
cular walls are free from surrounding glia and contact
the vitreous fluid directly.10 Ultrastructural and per-
meability studies have shown clearly that these ves-
sels behave like true retinal vessels and have the fea-
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tures that characterize blood-retinal barrier vessels in
other species.10"
Materials and Methods
These studies were performed using microperfu-
sion techniques adapted from kidney tubule studies
first described by Burg and co-workers.7
Dissection Technique
The investigations described adhered to the ARVO
Resolution on the Use of Animals in Research. Male
New Zealand white rabbits, weighing less than 2.5 kg
each (1.8-2.2 kg), were decapitated. The eyes were
removed quickly and placed in a Petri dish (diameter,
90 mm) containing cold (4°C) oxygenated, physio-
logic salt solution supplemented with 4% normal
rabbit serum. Under a binocular dissecting micro-
scope (Olympus stereo microscope, model SZ III;
Woodbury, NY) the eyes were bisected at the ora
serrata, and the anterior segment with adherent vitre-
ous was separated from the posterior pole. A fiberop-
tic light source (Dolan-Jenner Illuminator, 180 dual
branch fiberoptic; Scientific Supply, Chicago, IL) il-
luminated the tissue. The Petri dish was placed on
black paper so that the vessels, in contrast to the
black, could be seen clearly.
The visible vessels were confined to wing-shaped
areas of medullated nerve fibers that were extended
horizontally on either side of the disc, and lay in the
vitreous free from surrounding glia.410 Individual ret-
inal vessels, apparently arterioles, were stripped away
with jeweller forceps by freehand dissection, and a
relatively long, unbranched segment of vessel was
isolated after its ends were cut with sharp scissors. It
was necessary to make the final cuts with the finest
possible instruments at temperatures no higher than
4°C. Without these precautions, a spasm of the vessel
and closure of the lumen could have occurred, mak-
ing cannulation difficult or impossible and possibly
resulting in structural damage. The perfused length
of rabbit retinal vessels varied between 0.18 and
0.48 mm.
Transfer of the Vessels
To avoid pulling the vessels through an air-water
interface, we transported them to the perfusion
chamber with a transfer pipette (made from a Pasteur
pipette, bent at a 45° angle). The tip was fire-polished
to prevent adherence of vessels. A metal holder sup-
ported the pipette, while a screw pressed on a rubber
bulb at the rear of the pipette to control the flow of
fluid. The vessel could be sucked easily into the tip of
the pipette with the dissection fluid and then expelled
into the cannulation chamber. A flat field objective
was needed to provide a wide field for viewing the
vessel as it was introduced into the cannulating
chamber. It was necessary to ensure that solutions
contained protein during all transfer operations and
that they were cold, to prevent the vessel from stick-
ing to the wall of the pipette.
Cannulation, Microscope, and Tissue Chamber
The apparatus we used to cannulate isolated mi-
crovessels was adapted with minor modifications
from a design originally developed by Burg et al7 for
use on isolated kidney tubules.
To perfuse a suitable vessel, a perfusion-holding
pipette engaged one end of the vessel by gentle suc-
tion, and the perfusion pipette was advanced into the
lumen (Fig. 1). The vessel was then aspirated to
achieve as tight a seal as possible. A third, fluid-ex-
change, pipette was inserted into the perfusion pi-
pette. Appropriate valves were adjusted to place the
perfusion fluid into the tip of the perfusion pipette
within seconds, while draining waste fluid out. In this
way, a variety of solutions could be tested on a single
vascular segment. The other end of the vessel was
then aspirated into another micropipette (a collec-
tion-holding pipette), with a tip diameter approxi-
mately equal to that of the vessel. The quality of the
seal was improved by precoating the pipettes with
encapsulating resin (Sylgard 184; Dow Corning,
Midland, MI). The tip of the collection-holding pi-
pette was filled with water-equilibrated mineral oil,
which prevented evaporation but caused no signifi-
cant resistance to flow. All accumulated fluid was
collected at periodic intervals into a calibrated pi-
pette.
The pipettes were mounted in acrylic holding
pieces fitted within specifically designed aluminium
V-Tracks (White instruments, Suitland, MD) (Fig.
2).12 Each V-Track was mounted at a 30° angle to the
horizontal plane atop a micromanipulator (Brink-
man; White Instruments), which provided move-
ment along both axes of the horizontal plane. The
pipette arrangement moved vertically by elevating
column supports (J. H. Emerson, Cambridge, MA)
that were positioned below the micromanipulator.
The perfusion chamber was mounted above an in-
verted microscope (Olympus IMT 2; Scientific Sup-
ply), similar to the one described by Burg et al.7 The
perfusion chamber held approximately 0.5 ml of
bathing medium, which was exchanged continuously
throughout the course of an experiment without dis-
turbing the vessel. The temperature of the fluid in the
chamber was monitored by a Temperature Con-
troller (Yellow Springs Instrument, Yellow Springs,
OH), and the output of the heater was regulated by a
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PerliiMon Pipette Volumetric Pipette
Fig. 1. (A) Schematic of a
cannulated retinal vessel.
(B) The cannulated retinal
vessel is 0.25 mm long and
has an outside diameter of
0.06 mm. As in the sche-
matic, the perfusion-hold-
ing pipette on the left, and
the collection-holding pi-
pette is on the right. (X40)
Sylgard
Perfusion Holding Pipette Collection Holding Pipette
Mineral Oil
fluid changing Pipette
A
B
feedback controller. The bathing medium pH and
PO2 was regulated with a gas mixture (93% O2,
7% CO2).
The size and shape of the pipettes were critically
important to the success of the experiments. A mi-
croforge equipped with a microscope (Stoelting, Chi-
cago, IL) was used to form the tips and shapes of the
pipettes. It was necessary for the holding-perfusion
and perfusion pipettes to be concentric, and for the
perfusion pipette to be pulled down into a long
straight tip with an external diameter of 15-22 ^m.
More complex was the perfusion-holding pipette,
which had one constriction with a diameter of 21-28
nm and an outer opening of 85 /xm. The collection-
holding pipette had an opening slightly smaller than
the diameter of the vessel, approximately 35 nm. The
volumetric collecting pipette was designed so that the
expected perfusion rate and the desired collection
time would determine the necessary volume of the
pipette.
The physiologic solution used in these experiments
was a modified Krebs Ringer bicarbonate buffer
(KRBB; 25 mM, 297 mOsm/kg), which was com-
posed of 114 mM NaCl, 1.9 mM K2HPO4, 10 mM
Na acetate, 0.5 mM MgSO4,0.7 mM CaCl2, 5.6 mM
alanine, 2.5 mM dextrose, and 25.0 mM NaHCO3.
The solution was bubbled with 93% O2/7% CO2 in
the perfusion chamber. Preliminary studies showed
that 7% CO2 maintained the bath at pH 7.4 at 37°C.
Absence of plasma proteins appeared to increase
the hydraulic conductivity and permeability of the
capillary wall to small solutes and to decrease the
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Fig. 2. Schematic of the experimental apparatus. A, perfusate
reservoir; B, pump; C, light source; D, temperature controller; E,
O2/CO2 gas source; F, inverted microscope; G, micromanipulator;
H, elevator; I, stable base; J, chamber; K, V-track. Modified from
Chonko AM, Irisch JM, III, and Welling DJ: Methods Find Exp
Clin Pharm 4(B):221, 1978.12 See text for detailed description of
apparatus.
selectivity of the wall to macromolecules. We had
demonstrated this phenomenon by replacing the
serum with 1% albumin in three experiments. Ac-
cordingly, sterile normal rabbit serum was main-
tained at 4% in both the perfusate and the bath in
order to preserve the endothelial properties and the
osmotic equilibrium across the vessel wall.
Once the vessels were mounted on the microperfu-
sion apparatus, they were perfused with 0.3% trypan
blue in the physiologic solution, to allow rapid detec-
tion of any macroscopic vascular tear created during
dissection. Tryptan blue was advantageous in that it
rapidly identified microscopic holes and also stained
damaged cells.13
The vessels could leak at two sites: at points where
the endothelial cells have been inadvertently crushed
or pinched during the isolation procedure, and at
branch points where capillary-sized vessels leave the
main vessel (so-called hairpin capillary loops, which
dip into the natural spaces between the nerve fibers
and are severed when the larger vessel is peeled from
the nerve fiber layer during dissection). Leaking ves-
sels were discarded and replaced until one that had no
leaks was mounted. Occasionally, if a branch point
was close to the collection pipette, it could be drawn
inside the collection pipette and the vessel used for
perfusion experiments.
In all studies, a 45-min equilibration period pre-
ceded the experiment. During this time the vessel was
heated to 37°C and the perfusion rate was adjusted.
Three control collections were performed at the be-
ginning of each study; then the appropriate bath or
perfusion change was performed, followed by an
equilibration period of at least 10 min. This proce-
dure was repeated for each experimental episode.
Determination of Radioactivity
For 14C and 3H determinations, aliquots of perfu-
sion, collection, and bathing fluids were placed in
vials with 0.5 ml of acetic acid, to which was added 10
ml of Scintiverse II (Fisher Scientific, Fair Lawn, NJ).
Samples were counted on a Beckman niodel LS7000
liquid scintillation counter, the windows of which
were adjusted to give <0.1% 3H activity in the 14C
channel and 25-30% 14C activity in the 3H channel.
Standard techniques were used to correct count
rates to activities for each isotope.
Protocols
These studies followed a series of planned steps to
test the preparation for the investigation of transport
across retinal vessels.
Dilution ofinulin and fluid flux across retinal ves-
sels: A perfusate containing 100 /iCi/ml of methoxy-
3H inulin (specific activity, 385.5 mCi/g) was passed
through isolated retinal vessels, and its dilution (col-
lected vessel inulin fluid counts per perfusate counts
of inulin per unit volume; CLYO,') and fluid flux (Jv)
were determined.
The fluid flux Jv (absolute volume of fluid trans-
ported, in nl/min/mm), was calculated, as described
previously89 from the difference between the rates of
collection (VL) and perfusion (Vo), and normalized
per millimeter of perfused retinal vessel length (L):
Jv =
V L -V C (1)
Quantitative comparisons of transport rates
usually are based on a flux per unit length. Changes in
vessel diameter induced by differing perfusion pres-
sures and the outflow constriction at the collection
end have appeared to make calculations based on
surface area less accurate.14 The rates of perfusion
(Vo) and collection (VL) were obtained easily from the
experiment. Vo (nl/min) was calculated from the rate
of collection of 3H inulin:
QjVcp (2)
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Where CL' Vcp is the total amount of radioactivity
in the collecting calibrated pipette, and Vcp is the
volume of the calibrated collecting pipette; Co' is the
concentration of inulin in the perfusion fluid; and t is
the duration of the collection period. VL (nl/min) was
determined directly from the time required to fill the
calibrated micropipette.
Fluorescein dilution in reference to inulin: Lumen-
to-bath fluorescein fluxes were measured from the
rates of loss of radioactively labeled fluorescein from
the luminal perfusate in reference to inulin.
The perfusate contained 5 /wCi/ml of 9-carboxy-14C
sodium fluorescein (original specific activity, 18.48
mCi/mmol) together with 100 /iCi/ml 3H inulin for
perfusion rates and fluid flux measurements.
The fluorescein lumen to bath flux was computed
as the difference between perfused and collected
amounts of fluorescein, normalized per millimeter
vessel length, and calculated as
V C f — V,
v
 o ^-o v L
Fluor
(3)
where Jl -*- b ls the lumen-to-bath fluorescein flux
Fluor
(X10~12 mol/min/mm); Cof and CLf are the measured
concentrations of fluorescein in the perfusate and the
collected fluids; VL is the measured collection flow
rate; and Vo is the perfusion rate, calculated from the
change in inulin concentration.
Net lumen to bath fluorescein flux measurements
were performed in six retinal vessel segments, before
and after competitive inhibition by probenecid. In
some vessel segments, the probenecid effect was
tested first in the perfusate and then in the bath. After
three to four initial determinations of the 3H inulin
and I4C fluorescein dilutions in each vessel, probene-
cid (3.25 X 10~4 M) was added either to the perfusate
or to the bath.
In four experiments, the viability of the prepara-
tion (approximate survival time) was tested by exam-
ining the lumen-to-bath fluorescein flux at different
time intervals, up to 5-6 hr after vessel dissection.
In another series of four experiments, we studied
the behavior of the net outflux of fluorescein with
increasing concentrations of probenecid in the bath
(3.25 X 10"6 M, 3.25 X 10"5 M, and 3.25 X 10~4 M).
Bath-to-lumen fluorescein fluxes across retinal ves-
sels: Bath-to-lumen fluorescein fluxes Jb -»• * w e r e
Fluor
computed from the rate of appearance of l4C-labeled
fluorescein in the collected luminal solution, when
the initial perfusate contained no fluorescein. 14C flu-
orescein was added to the bathing solution to a total
activity of 3-5 ^Ci/ml. The perfusate contained
60-100 /iCi/ml of 3H inulin to determine the perfu-
sion rate and fluid flux across the retinal vessels.
After three to four determinations in each vessel
with only 3H inulin in the perfusate, 14C fluorescein
was added to the bath.
The influx (secretion) of fluorescein from bath to
lumen was calculated as proposed by Shimomura
et al,15 as
Jb
v L c L
f
Fluor
(4)
where Jb -»• 1 is the secretion rate (XI0 mol/min/
Fluor
mm); VL is the rate of vessel fluid collection; CLf is the
concentration of 14C fluorescein in the collected fluid;
and L is vessel length. To examine the movement of
fluorescein from bath to lumen under competitive
inhibition, probenecid (3.25 X 10~4 M) was added
later to the bath.
The fluorescein fluxes were calculated after nor-
malizing fluorescein percent dilution to inulin.
Coupling of fluorescein transport with fluid flux in
retinal vessels: The relationship between fluorescein
transport and net fluid secretion was studied under a
variety of conditions: 1) with increasing concentra-
tions of fluorescein in the bath; 2) with fluorescein in
the perfusate; 3) under competitive inhibition (pro-
benecid), either in the perfusate or bath, when fluo-
rescein was either perfused or only added to the bath;
and 4) with increasing concentrations of probenecid
in the bath when fluorescein was perfused.
Statistical analysis: Measurements for a given ves-
sel were averaged for each experimental period. In
general, there were four or five fluorescein flux and Jv
measurements in each period. The mean values from
individual vessels then were used to compute an
overall mean and standard error of the mean. Means
from different groups of vessels were compared by the
student t-test.
Results
Dilution of Inulin and Fluid Flux
Across Retinal Vessels
When 3H inulin was perfused through the retinal
vessel segments, its dilution (CL7CO' ratios) remained
at 80.2 ± 2.3% over a fairly wide range of perfusion
rates (5.2-18.5 nl/min; Table 1).
This dilution was due apparently to fluid flux from
bath to lumen across the retinal vessels. The total
radioactivity due to 3H inulin in each collected sam-
ple varied from 4000 to 7000 counts per 10 min. If
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10% of the label had been lost into the bath during the
10-min collection period, then the total bath counts
would have varied from 400 to 700 counts per 10
min. However, when the total bath was measured,
there were no detectable counts. We believe, there-
fore, that 3H inulin was a suitable volume marker.
Tissue uptake of 3H inulin probably was not a source
of error, since each vessel was perfused for at least 15
min before the first collection, a period which allowed
more than adequate time for equilibration of 3H inu-
lin in a tissue with less than 1 nl total volume.9
The fluid flux from bath to lumen across the retinal
vessels was calculated as 6.3 ± 1.0 nl/min/mm for
perfusion rates of 6.6 ± 0.2 nl/min. Higher perfusion
rates (15.2 ± 0.3 nl/min) caused an increase in water
reabsorption (20.3 ± 2.8 nl/min/mm) and an in-
crease in tracer dilution. To test the effect of the per-
fusion rate on the experimental preparation and dilu-
tion values of the reference tracer, we examined, in
the same vessel, the correlation between fluid flux
and perfusion rate. When perfusion rates were main-
tained at values of less than 10 nl/min, dilutions were
reproducible and independent of the perfusion rates.
However, when the perfusion rates reached values
higher than 10 nl/min, more variability was apparent.
A lower albumin concentration in the perfusate
increased markedly the permeability of the retinal
vessels, as shown by higher inulin dilutions. When
the concentration of albumin was decreased from 4%
to 1% in the physiologic solution both in the perfusate
and bath, the CLYO,' ratios were only 55.1 ± 5.2%
(three experiments), with perfusion rates of 7.1 ± 1.3
nl/min.
Fluorescein Dilution in Reference to Inulin
When 14C fluorescein was perfused simultaneously
with the reference tracer, its dilution (CLf/Cof ratio)
remained at 81.9 ± 3.8% over a wide range of perfu-
sion rates (Table 1). The values for fluorescein dilu-
tion were strikingly similar to those obtained for in-
ulin.
In order to examine the survival time and func-
tional viability of the preparation, we saw that
lumen-to-bath fluorescein fluxes remained fairly
constant for the first 4 hr; thereafter, increases of
30-83% occurred (Fig. 3). All experiments therefore
were performed within a 4-hr time interval.
Net lumen-to-bath fluorescein measurements be-
fore and after competitive inhibition by probenecid
are shown in Figure 4. The initial perfusate contained
2.5 X 10~4 M of 14C fluorescein, with perfusion rates
varying from 3.9 to 6.3 nl/min. The extremely low
lumen to bath fluorescein flux values, 0.5 ± 0.9
X 10"12 mol/min/mm, increased by 68% (0.05 < P
< 0.1) when probenecid was added to the perfusate
and by 210% (0.01 < P < 0.025) when probenecid
was placed in the bath.
As higher concentrations of probenecid were added
to the bath, we found that the lumen-to-bath fluores-
cein flux values also increased (Fig. 5; comparing
with baseline, 0.01 < P < 0.025, 0.0005 < P < 0.005,
and 0.0005 < P < 0.005, for probenecid concentra-
tions of 3.25 X 10~6 M, 3.25 X 10"5 M, and 3.25
X 10~4 M, respectively). The flattening of the curve at
the higher probenecid concentrations in the bath ap-
peared consistent with a saturable process of fluores-
cein reabsorption.
Since the bath volume was approximately 0.5 ml
and the total fluid perfused during the course of an
experiment was approximately 1 /nl, fluorescein con-
centrations in the bath solution were insignificant in
comparison to those in the luminal solution, under
all experimental conditions. Accordingly, any error
due to backflux of fluorescein from bathing solution
to the lumen could be neglected.
Table 1. Results obtained with the reference tracer 3H-inulin and 14C-fluorescein in seven experiments
Vessel
length (L)
(mm)
0.25
0.32
0.28
0.25
0.18
0.22
0.37
Total
(%) inulin
80.5 ± 2.2
71.9 ±0.7
81.5 ± 1.4
84.2 ± 0.3
89.3 ± 1.6
80.0 ± 0.6
73.7 ±0.9
80.2 ± 2.3
Time
(min)
6.5 ± 1.3
6.6 ± 0.8
7.3 ± 0.4
5.2 ± 0.8
5.6 ± 0.7
5.7 ± 0.2
5.5 ±0.1
Pipette
size
(nl)
47.7
47.4
47.0
47.0
110.3
108.0
110.1
vL(nl/min)
7.8 ± 1.6
7.5 ± 0.8
6.4 ± 0.3
9.6 ± 1.4
20.5 ± 2.4
19.1 ±0.7
20.3 ± 0.4
Vo
(nl/min)
6.3 ± 1.5
5.4 ± 0.6
5.2 ± 0.3
8.0 ± 1.2
18.5 ±2.4
15.2 ±0.6
15.0 ±0.4
VL-VO
(nl/min)
1.5 ±0.1
2.1 ±0.3
1.2 ±0.1
1.6 ±0.2
2.0 ±0.1
3.9 ±0.1
5.3 ±0.1
•A,
(fluidjlux),
(nl/min/mm)
5.9 ±0.5
6.6 ± 0.7
6.4 ± 0.6
6.1 ±0.9
11.2 ±0.5
17.4 ±0.5
14.5 ±0.4
CJC0
fluorescein
72.3 ± 1.8
84.6 ±
80.6 ±
89.6 ± (
86.7 ±
65.8 ±
.1
.4
).7
.6
.2
94.1 ± 0 . 3
81.9 ±3 .8
Each value represents mean ± SE of three to seven collection periods.
Shown are the percent dilution of collected fluid (CL/Co), the collection
rate (VL), perfusion rate (Vo), net fluid entry (VL - Vo), vessel length (L), and
fluid flux (Jv) for each experiment.
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Fig. 3. Relationship between flux of fluorescein from lumen to
bath (Jl -*• b) and duration of the experiment.
Bath-to-Lumen Fluorescein Fluxes
Across Retinal Vessels
When 14C fluorescein was added to the bath, with
only 3H inulin in the perfusate, fluorescein rapidly
moved from bath to lumen across the retinal vessel
walls, reaching a concentration in the collection fluid
1.3 times the concentration of the initial fluorescein
bath, resulting in perfusion rates of 6.4-7.5 nl/min
and time periods not exceeding 10 min. When the
perfusion rates were slowed to 0.3 nl/min, the fluores-
cein concentration in the collection fluid became as
high as 40 times that in the bath.
The values of Jb - • 1 f o r higher perfusion rates
Fluor
(6.4-7.5 nl/min) and with different concentrations of
fluorescein in the bath are presented in Figure 6.
Even with fluorescein concentrations in the bath
lower than those in the lumen, the bath-to-lumen
fluorescein fluxes were always much higher than the
Fig. 4. Effect of probenecid (Prob.) on the flux of fluorescein
from lumen to bath (Jl -* b). (A) Probenecid in the perfusate; (B)
Fluor
probenecid in the bath.
' o
3.25 x 10* 3.25 x 10s 3.25 x 10'4
BATH PROBENECID CONCENTRATION (M)
b) is plotted as aFig. 5. Lumen-to-bath flux of fluorescein (Jl
Fluor
function of bath probenecid concentration (four experiments).
Means and SEs (vertical line segments) are given.
lumen-to-bath fluorescein fluxes. All retinal vessel
segments showed a concentration-dependent flux of
fluorescein from bath to lumen that increased with
increasing fluorescein concentrations in the bath.
Again, the flattening of the curve at higher fluorescein
levels in the bath appears consistent with the Mi-
chaelis-Menten equation. The average Michaelis
constant (Km) was 1.1 X 10~4 M. When probenecid
was added to the bath, much less fluorescein moved
from bath to lumen (Fig. 6; 0.025 < P <; 0.05, 0.01
< P < 0.025, and 0.01 < P < 0.025, for fluorescein
concentrations of 0.87 X 10~4 M, 1.5 X 10"4 M, and
2.5 X 10"4 M, respectively.
15
10
«-* 5
1 1.5 2 2.5
BATH FLUORESCEIN CONCENTRATION (x10" 4 M)
Fig. 6. Relationship between the fluorescein concentrations in
the bath and the flux of fluorescein from bath to lumen (Jb -*• 0
Fluor
before (solid line) and after (dashed line) addition of probenecid
(3.25 X 10~4 M) to the bath (10 experiments). Means (circles,
before probenecid; triangles, after probenecid) and SEs (vertical
line segments) are given.
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In all experiments, no correlation of Jb -*•
Fluor
elapsed time was observed, indicating that the system
was in a steady state.
Coupling of Fluorescein Transport with
Fluid Flux in Retinal Vessels
Net fluid secretion across the retinal vessels in re-
sponse to increasing concentrations of fluorescein in
the bath is illustrated in Figure 7. In the initial control
period, net fluid flux was 6.3 ± 1.0 nl/min/mm with
perfusion rates of 6.6 ± 0.2 nl/min. After the addition
of 1.5 X 10"4 M fluorescein to the bath, the rate of net
fluid secretion increased by 36% (0.0005 < P
< 0.005), and increased by 60% (P < 0.0005) when a
concentration of 2.5 X 10~4 M of fluorescein was
added to the bath. In another set of experiments,
when fluorescein was added to the perfusate (2.5
X 10~4 M), there was a smaller increase in the rate of
net fluid secretion (a mean of 17% from a total of 16
experiments; data not shown).
To examine further the coupling of fluorescein
transport with fluid secretion, we studied the effect of
probenecid on the rate of fluid secretion. First, fluo-
rescein added to the bath always caused an increase in
net fluid flux across the retinal vessel walls. The sub-
sequent addition of probenecid (3.25 X 10~4 M) in-
hibited fluid flux by approximately 39% (0.01 < P
< 0.025) for a concentration of 1.5 X 10"4 M and by
28% (0.01 < P < 0.025) for a concentration of 2.5
X 10"4 M of fluorescein in the bath (Fig. 7).
A similar situation occurred when fluorescein was
present in the perfusate. Subsequent additions of
probenecid to the perfusate decreased net fluid flux
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Fig. 7. Relationship between the fluorescein concentration in the
bath and the fluid flux (Jv) before (solid line) and after (dashed line)
addition of probenecid (3.25 X 10"4 M) to the bath (10 experi-
ments). Means (circles, before probenecid; triangles, after probene-
cid) and SEs (vertical line segments) are given.
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Fig. 8. Fluid flux (Jv) is plotted as a function of bath probenecid
concentrations (four experiments). Means and SEs (vertical line
segments) are given.
by approximately 22%, and by approximately 61%
when added to the bath. When increasing concentra-
tions of probenecid were added to the bath (3.25
X 10"6 M, 3.25 X 10~5 M, and 3.25 X 10"4 M), a
dose-dependent effect was observed again: the fluid
flux decreased with increasing concentrations of pro-
benecid in the bath (Fig. 8).
Finally, we verified that the fluid flux measured in
the isolated retinal vessel preparations is tempera-
ture-dependent. When the temperature was de-
creased to 13°C in four experiments, the rate of fluid
secretion was reduced by 19-35%. This effect was
reversed easily when the temperature was increased,
and fluid flux values were restored to previous levels
(data not shown).
Discussion
Our findings show that microperfusion studies of
the rabbit retinal vessels are feasible, reproducible,
and may yield important data to our understanding
of retinal vascular physiology. Specifically, we found
1) a unidirectional movement of fluorescein across
the retinal vessel walls, which may be due to a more
general active transport for organic anions; 2) evi-
dence for a net fluid flux from outside the vessel walls
to the lumen; and 3) stimulation of this fluid flux by
the fluorescein transport.
Throughout the study we used the conventional
method of measuring net fluid transport in isolated
renal tubules.8'9 In the kidney, fluid movements were
calculated in tubules perfused with a volume marker
such as inulin or albumin; the perfusate was collected
quantitatively from the distal end of the tubule in a
pipette; and from the change in the concentration of
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the volume marker, the amount of fluid absorbed by
the tubule was determined.8'9
The perfused vascular segments studied were rela-
tively short, in order to avoid branchings and conse-
quent leaks. This shortness initially was a source of
concern, but we found that reproducible changes
could be detected even with these relatively short reti-
nal vascular segments.
When fluorescein was added to the perfusate, its
dilution remained at the same level as that of inulin,
suggesting minimal or no movement of fluorescein
from lumen to bath. This observation was notewor-
thy because of the difference in molecular size be-
tween fluorescein and inulin. If the retinal vessel wall
behaved as a semipermeable barrier to fluorescein,
movement from lumen to bath would be larger than
with inulin.
When fluorescein was added to the bath, its passage
across the retinal vessel walls rapidly resulted in con-
centrations in the lumen that reached levels as high as
40 times those in the bath. This concentrating effect
was better achieved when lower perfusion rates were
used. Using faster perfusion rates, this movement of
fluorescein from bath to lumen was clearly concen-
tration-dependent, and it increased with higher con-
centrations of fluorescein in the bath. The flattening
of the curve at higher bath fluorescein levels appears
consistent with a saturable process. Furthermore, the
upper limit of the rate of transport was obtained with
fluorescein concentrations similar to those presented
by Cunha-Vaz and Maurice.4
The observation that fluorescein when placed only
in the bath could be brought to higher concentrations
in the lumen demonstrates movement against an
uphill gradient. This striking difference in the move-
ment of fluorescein from bath to lumen and lumen to
bath in the same experimental conditions supports
the existence of a unidirectional movement of fluo-
rescein across the retinal vessel walls.
When probenecid, a competitive organic anion
transport inhibitors, was added to the bath, it in-
creased markedly the fluorescein movement from
lumen to bath, and inhibited fluorescein uptake into
the lumen.
The observed saturation kinetics of the fluorescein
movement across the retinal vessel walls; the specific
inhibition of fluorescein movement by a competitive
inhibitor; its unidirectional characteristics; and its
maintenance in a situation of uphill gradient all sup-
port the idea that an active transport process was
involved.
Active transport of organic anions such as iodo-
pyracet16 and fluorescein4 have been postulated to
occur from vitreous to blood across the retina and
retinal vessels. More recently, a similar active out-
ward transport of fluorescein was reported in the an-
terior uvea17 and choroid plexus18 of the rabbit, with
Km values of 1.2 X 10~4 M and 4 X 10"5 M, respec-
tively. The Km for fluorescein observed in our study,
1.1 X 10~4 M, is in the same range. Our findings are
the first direct demonstration of an active outward
movement of fluorescein across the retinal vessel
walls.
The observation that competitive inhibition by
probenecid is significantly more effective when it is in
the bath suggests a difference between the basal and
luminal membranes of the retinal vascular cells in-
volved in the organic anion transport, presumably
the endothelial cells.
An important finding was the observation of a sur-
prisingly high fluid flux across the retinal vessel wall
from bath to lumen. This bath-to-lumen fluid flux
remained constant when perfusion rates of less than
10 nl/min were used. However, variable values of
fluid flux were observed with perfusion rates higher
than 10 nl/min. As perfusion rates increased, CL7C0'
ratios decreased, but fluid flux increased, and small
errors became magnified. We felt that high rates of
perfusion yielded less reliable results. Therefore,
throughout our studies, we used perfusion rates of
less than 10 nl/min.
This bath-to-lumen fluid flux was temperature-de-
pendent and appeared to be coupled to the organic
anion transport. Fluorescein stimulated the fluid flux
by 17% when added to the perfusate and by 60%
when added to the bath. It was also partially inhibited
by probenecid. A fluid flux coupled to the active
transport of an organic anion, p-aminohippuric acid,
has been shown to occur in the proximal straight
tubule. The involvement of the sodium-potassium
pump, as shown by its inhibition by ouabain, was one
of explanations offered.19
Although there is indirect evidence for interstitial
fluid secretion in the brain,20 similar studies in iso-
lated preparations of brain vessels are lacking,
namely because of problems associated with the me-
chanical or enzymatic homogenization procedures
used for isolation.21
The retinal vessels may function as selective tu-
bules which facilitate the penetration of oxygen and
glucose into the retina, but may have a very active
fluid flux from the retina into the blood, which keeps
the retina relatively dry and maintains the appro-
priate environment for optimal neural tissue func-
tion.
Any alteration of these transport systems may be of
major clinical significance. Macular edema is an im-
portant cause of visual loss and is frequently concom-
itant in retinal vascular disease. Recently, when re-
viewing basic concepts of retinal edema,22 we dis-
480 INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE / March 1990 Vol. 31
cussed the importance of a variety of factors in its
development, such as plasma and tissue osmotic
pressure, blood-retinal barrier diffusion, capillary
and tissue hydrostatic pressure, and tissue compli-
ance. Alterations of fluid flux from retina and vitre-
ous to blood may well be the principal cause of retinal
edema. Further studies are needed to characterize this
fluid flux across the retinal vessel walls and its depen-
dence on other ionic movements.
The development of this new experimental model
for microperfusion studies of the rabbit retinal vessels
has opened new perspectives for future research in
retinal vascular physiology and pharmacology.
Key words: retinal vessels, fluorescein, microperfusion, per-
meability, fluid flux
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